PMC:7795856 / 46-233 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"18","span":{"begin":82,"end":85},"obj":"Gene"},{"id":"20","span":{"begin":140,"end":157},"obj":"Species"},{"id":"24","span":{"begin":159,"end":162},"obj":"Species"}],"attributes":[{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Gene:134864"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:10407"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:10407"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mulatory Peptide for Applications in Oncology and Virology\n\nAbstract\nThymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus ("}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":37,"end":45},"obj":"Phenotype"},{"id":"T2","span":{"begin":140,"end":149},"obj":"Phenotype"},{"id":"T3","span":{"begin":168,"end":177},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"mulatory Peptide for Applications in Oncology and Virology\n\nAbstract\nThymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus ("}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":60,"end":68},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"mulatory Peptide for Applications in Oncology and Virology\n\nAbstract\nThymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus ("}